Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
10/17/2024 | Neutral | BTIG Research | |
5/14/2024 | $8.25 → $5.00 | Outperform → Market Perform | Leerink Partners |
11/11/2022 | $4.00 | Overweight → Neutral | Piper Sandler |
6/16/2022 | $17.00 → $8.50 | Overweight → Equal-Weight | Morgan Stanley |
11/23/2021 | $18.00 | Outperform | Raymond James |
11/23/2021 | $17.00 | Overweight | Morgan Stanley |
11/23/2021 | $26.00 | Outperform | SVB Leerink |
11/23/2021 | $22.00 | Overweight | Piper Sandler |
BTIG Research initiated coverage of AirSculpt Technologies with a rating of Neutral
Leerink Partners downgraded AirSculpt Technologies from Outperform to Market Perform and set a new price target of $5.00 from $8.25 previously
Piper Sandler downgraded AirSculpt Technologies from Overweight to Neutral and set a new price target of $4.00
MIAMI BEACH, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), an industry leader and provider of premium body contouring procedures, today announced the appointment of Yogi Jashnani as Chief Executive Officer ("CEO") and a member of the Board of Directors. He succeeds Dennis Dean, Interim Chief Executive Officer and Chief Financial Officer who will continue as Chief Financial Officer, all effective January 7, 2025. A highly-talented, results oriented executive with an accomplished career spanning more than two decades, Mr. Jashnani has architected successful transformations for public and private companies in the aesthetics
SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)
SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)
SC 13G - Airsculpt Technologies, Inc. (0001870940) (Subject)
MIAMI BEACH, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), an industry leader and provider of premium body contouring procedures, today announced an update to its fiscal year 2024 guidance. The Company is providing this information in conjunction with participating in the ICR Conference 2025. "Last week marked my official start as CEO of AirSculpt and I am excited to utilize my experience and create the plan that maximizes the power of our brand and leverages our innovative body contouring procedures and our asset-light business model to generate consistent, long-term profitable growth," stated Yogi Jashnani,
MIAMI BEACH, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), an industry leader and provider of premium body contouring procedures, today announced that it will participate in investor meetings and host a presentation at the ICR Conference 2025 being held at The Grande Lakes Orlando in Orlando, Florida on January 13, 2025 through January 14, 2025. Chief Executive Officer, Yogi Jashnani, and Chief Financial Officer, Dennis Dean, will host a presentation on Tuesday, January 14, 2025, at 10:00 a.m. Eastern Standard Time. The presentation will be webcast live at https://investors.airsculpt.com. An archive of the webcast presen
MIAMI BEACH, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), an industry leader and provider of premium body contouring procedures, today announced the appointment of Yogi Jashnani as Chief Executive Officer ("CEO") and a member of the Board of Directors. He succeeds Dennis Dean, Interim Chief Executive Officer and Chief Financial Officer who will continue as Chief Financial Officer, all effective January 7, 2025. A highly-talented, results oriented executive with an accomplished career spanning more than two decades, Mr. Jashnani has architected successful transformations for public and private companies in the aesthetics
MIAMI BEACH, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), an industry leader and provider of premium body contouring procedures, today announced an update to its fiscal year 2024 guidance. The Company is providing this information in conjunction with participating in the ICR Conference 2025. "Last week marked my official start as CEO of AirSculpt and I am excited to utilize my experience and create the plan that maximizes the power of our brand and leverages our innovative body contouring procedures and our asset-light business model to generate consistent, long-term profitable growth," stated Yogi Jashnani,
MIAMI BEACH, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the third quarter and nine months ended September 30, 2024. "Our revenue and Adjusted EBITDA for the quarter were in line with our expectations with the period including progress on our strategy despite continued challenges in the consumer environment," said Dennis Dean, Interim Chief Executive Officer and Chief Financial Officer of AirSculpt Technologies, Inc. "We are pleased with our four new center openings during the quarter and our 2023 de novo class continues to surpass ou
Expects 2024 Revenue in the Range of $183 Million to $189 Million Announces Third Quarter Fiscal 2024 Earnings Date and Conference Call MIAMI BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced selected unaudited preliminary financial results for its third quarter ended September 30, 2024. For the third quarter, revenue is expected to be approximately $42.5 million, a decrease of approximately 9% over the prior year. Same store cases declined 8.1% over the prior year period. "While we continue to see top line pressures primarily from macro-econo
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
3 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)
8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)
8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)